Latest Premenstrual syndrome Stories
Recent studies report that women suffering severe premenstrual syndrome (PMS) who take sertraline, more commonly known as Zoloft, for 4 months face higher risks for reoccurrence than women who practice 12 month regiments of the medication.
About half of women whose symptoms of severe premenstrual syndrome are relieved by the antidepressant sertraline appear to experience relapse within six to eight months after stopping medication.
New research from the University of Massachusetts finds that women 27 to 44 years old who smoke double their risk of suffering from premenstrual syndrome (PMS), particularly hormone-related symptoms such as bloating, backaches, breast tenderness and acne.
By ADEGBOYEGA ADEJANA For The Maryland Gazette As a woman, you are always on the move. But what most women don't realize is that your body is moving as well. As a natural caregiver, women are always worried about how to take care of their family, friends and pets.
WAYNE, N.J., Sept. 9 /PRNewswire/ -- Nina Garcia, judge of the Emmy-nominated series Project Runway, and the Step Up Women's Network are proud to announce the winner of the "YAZ(R): Step Up and Go Beyond" contest -- aspiring handbag designer Elayne Mayes of Green Village, New Jersey.
PMS is that dreaded term that many women - and men - dread every month. The emotional rollercoaster is thought to affect about eight out of 10 women - however, many younger women don't realise they have it and are being treated for depression and anxiety instead.
NEW YORK (Reuters Health) - A new low-dose oral contraceptive pill reduces symptoms of premenstrual syndrome, including a severe form called premenstrual dysphoric disorder, US researchers report.
A new study led by researchers at Yale School of Medicine shows for the first time that a low dose oral contraceptive is effective in treating symptoms of premenstrual dysphoric disorder (PMDD), the most severe form of premenstrual syndrome.
By David Douglas NEW YORK (Reuters Health) - Intermittent dosing of controlled release paroxetine (Paxil-CR) is successful for the treatment of premenstrual dysphoric disorder (PMDD), a condition characterized by symptoms of severe depression, irritability and tension, which occurs before menstruation, researchers report.